RxDoctor Payments Data

Mirel Sanchez, MD

Family Medicine · Miami, FLNPI 1740401322

Payments from drug & device makers

$2,331,997in general payments, 2019–2025

Across 748 payments — averaging $3117.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$721K
  • Boehringer Ingelheim$527K
  • Sanofi US Services Inc.$476K
  • Eli Lilly$182K
  • Boehringer Ingelheim International GmbH$119K
  • Janssen Research & Development, LLC$109K
  • plus $199K from 35 others
$153,512in research payments, 2019–2025

Across 26 payments — averaging $5904.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$82K
  • Janssen Research & Development, LLC$72K
  • Eli Lilly$36

What the payments were for

  • Travel & lodging$2,51420%
  • Food & beverage$10,10580%
  • Education$440%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,331,997 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$16,286
Medicare patients
26
Services billed
167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate40$26,705
EliquisApixaban40$26,652
XareltoRivaroxaban46$26,245
Soliqua 100-33Insulin Glargine/Lixisenatide22$18,034
Synjardy XrEmpagliflozin/Metformin Hcl21$16,856
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr29$16,696
TradjentaLinagliptin26$15,422
FarxigaDapagliflozin Propanediol16$14,050
JardianceEmpagliflozin15$12,661
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,228
Tresiba Flextouch U-200Insulin Degludec22$9,094
Janumet XrSitagliptin Phos/Metformin Hcl22$8,482
BrilintaTicagrelor18$7,967
MyrbetriqMirabegron11$5,083
Semglee (Yfgn) PenInsulin Glargine-Yfgn11$4,296

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimSynjardy Xr, Tradjenta, Jardiance$526,927$44,93862 claims
MerckJanuvia, Janumet Xr$142$35,18762 claims
GSKAnoro Ellipta, Trelegy Ellipta$277$27,92446 claims
PfizerEliquis$399$26,65240 claims
Johnson & JohnsonXarelto$844$26,24546 claims
AstraZenecaFarxiga, Brilinta$31,727$22,01834 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$447$18,03422 claims
Astellas Pharma US IncMyrbetriq$76$5,08311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →